Dry Eye in the Desert
Sunday, March 6, 2022
4 hours of COPE approved CE
Location: The Henry - 4455 E Camelback Rd, Phoenix, AZ 85018
and Online via Zoom
Time: 9:00 am - 2:00 pm MST
Agenda
*All times are in MST (Arizona time)
8:00 AM: Registration begins
8:20 AM - 8:50AM: Breakfast presentation from Dr. Marc Bloomenstein sponsored by Kala
9:00 AM - 9:50 AM: Dr. Marc Bloomenstein — “Expert Insights into Dry Eye”
This course will define dry eye disease, the multiple factors that contribute to this disease, the prevalence, the effects on patients, and treatment options available. A variety of diagnostic tools is discussed as well as modern treatment options.
10:00 AM – 10:50 AM: Dr. Caity Morrison — “The Role of Scleral Lenses in Dry Eye”
This course reviews scleral lenses as a fantastic treatment option for dry eye patients. Uncover good candidates within your own practice who might benefit from a scleral lens. Scleral lenses are an excellent therapeutic device for patients with dry eye, Sjogren’s, Stevens-Johnson, neurotrophic keratitis and more.
11:00 AM - 12:00 PM: Exhibit Hall - Network with some of your favorite dry eye companies while sipping on fabulous brunch cocktails.
12:00 PM – 12:50 PM: Dr. Walt Whitley — “What’s New in the Treatment of MGD and Blepharitis”
This lecture will discuss current and future diagnostic treatment options for blepharitis and MGD. Review eyelid scrubs, masks, drops, and other products that patients can use on a routine basis to improve their dry eye. Discover in-office procedures as well as at-home patient management resources.
1:00 PM – 1:50 PM: Dr. Anne Zaki — “Advanced Dry Eye Disease: New Levels, New Devils”
Dry eye patients can often be frustrating and challenging to manage. This course reveals some of the non-traditional treatment options (amniotic membranes, serum tears, biological eye drops, , nasal spray, neuro-stimulation, IPL and more) and when to integrate them into your patient’s dry eye plan.
1:50 PM – 2:00 PM: Raffle Winners Announced and Formal CE Event Conclusion
2:00 PM– 2:50 PM: Sponsor Lunch Presentation from Dr. Anne Zaki sponsored by Allergan
*This event is undergoing COPE approval for 4 hours of live continuing education.
Host
Dr. Stephanie Woo
Dr. Stephanie Woo is a graduate of the Southern California College of Optometry. She completed a cornea and contact lens residency at the University of Missouri, St. Louis. Dr. Woo is the owner of the Contact Lens Institute of Nevada, a clinic dedicated entirely to specialty contact lenses. Dr. Woo is a Fellow of the American Academy of Optometry and a Fellow of the Scleral Lens Education Society. Recently, she founded Woo University, an optometric education company. Dr. Woo enjoys lecturing on the topics of scleral contact lenses and anterior segment eye disease. Dr. Woo is the founder of Woo University.
Speakers
Dr. Marc Bloomenstein
Dr. Marc R. Bloomenstein is a 1990 graduate of the University of California at Los Angeles with a degree in Biology. He received his optometric degree from the New England College of Optometry in 1994. After graduation, Dr. Bloomenstein finished a residency in secondary ophthalmic care at the Barnet Dulaney Eye Center in Phoenix, Arizona. He received his fellowship from the American Academy of Optometry in December, 1998 and is a founding member of the Optometric Council on Refractive Technology.
Currently, Dr. Bloomenstein is at the Schwartz Laser Eye Center. Aside from lecturing and publishing on numerous anterior segment and refractive topics, Dr. Bloomenstein is on the editorial board of Primary Care of Optometry and Contemporary Optometry. Dr. Bloomenstein served as the President of the Arizona Optometric Association, as well as an Optometric Advisor to STAAR Surgical and Medtronics Solan. Dr. Bloomenstein is the President of the Board of the Arizona Optometric Charitable Foundation.
Dr. Caity Morrison
Dr. Morrison is passionate about designing specialty contact lenses to restore sight to those who have lost vision due to severe ocular surface conditions including keratoconus, pellucid marginal degeneration, radial keratotomy, corneal scarring, pediatric aphakia, severe dry eye, corneal transplants, and ocular disfigurement.
After graduating from the New England College of Optometry in Boston, Dr. Morrison completed a Cornea & Contact Lens Residency at SUNY College of Optometry in New York City.
She is a Fellow in the American Academy of Optometry (FAAO), a Fellow of the Scleral Lens Society (FSLS), and the recipient of both the Bert C. and Lydia M Corwin Contact Lens Award and the Johnson & Johnson Award for Excellence in Contact Lens Patient care.
Dr. Walt Whitley
Dr. Whitley serves as the Director of Optometric Services and Residency Program Supervisor at Virginia Eye Consultants in Norfolk, Virginia where his practice encompasses ocular surface disease, glaucoma, surgical co-management, clinical research and the supervision of an extensive referral network. Dr. Whitley is a nationally recognized lecturer on topics ranging from ocular disease, surgical co-management, pharmaceuticals and practice management topics. He serves as Co-Chief Medical Editor for Advanced Ocular Care and contributing editor for the Review of Optometry and Optometry Times
Dr. Anne Zaki
Dr. Anne Zaki received her medical degree from the George Washington University School of Medicine in Washington, D.C. She completed her internship at Saint Elizabeth’s Medical Center in Brighton, Mass., and her residency at Boston University Medical Center. Dr. Zaki then completed an ophthalmology fellowship at the Baylor College of Medicine in Houston.
Dr. Zaki is Board Certified in Ophthalmology.
Dr. Zaki works at Desert Eye Specialists in Arizona.
Thank you to Bausch & Lomb, Alcon, Johnson & Johnson and Kala Pharmaceuticals for supporting this event with unrestricted educational grants.
Sponsors for Dry Eye in the Desert
DIAMOND
Allergan
Our mission is to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.
PLATINUM
Kala
Kala is a biopharmaceutical company focused on innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® Drug Delivery Technology to two ocular therapies, EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25% and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1%. The Company also has a pipeline of proprietary NCE development programs.
GOLD
Zeiss
As the pioneer of scientific optics, we continue to challenge the limits of human imagination. With our passion for excellence, we create value for our customers and inspire the world in new ways.
Physician Recommended Nutriceuticals®
Physician Recommended Nutriceuticals® partners with ophthalmologists and optometrists to provide patients with evidence-based nutriceuticals to enhance their long-term ocular health. PRN is committed to supporting the health, education, and well-being of those patients through superior customer service and the use of peer-reviewed clinical research that validates our product safety and benefits.
The TearCare® System
The TearCare® System is a device that is indicated for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction, when used in conjunction with manual expression of the meibomian glands. TearCare® allows the ECP the freedom to personalize the entire experience. Universally fitting SmartLids™ contour to the unique shape of every patients’ eyelid while delivering intelligent therapeutic heat between 41 C and 45 C. Following the heat therapy, the ECP will evacuate the meibum by performing manual expression of the glands with a personalized approach for each patient. The portable SmartHub™ monitors and maintains heat by communicating with the SmartLids™ 240 times a second to ensure the consistent therapeutic temperature to the eyelid.
Lumenis Vision
Since the introduction of the first laser photo coagulator to Vision Care in 1970, Lumenis Vision has focused on providing Physicians with innovative laser therapies to preserve and improve the sight of patients worldwide. Today, Lumenis Vision offers you the confidence of doing business with a company that is truly committed to Vision Care and to meeting your needs.
Sun Ophthalmics
Sun Ophthalmics is reenergizing eye care. We are a US division of Sun Pharma, a global specialty pharmaceutical corporation with operations in over 150 countries. Our mission is to launch innovative ophthalmic products that complement your approach to treatment. We focus on your unmet treatment needs in patient care so you can focus on your patients. Discover a brighter future in eye care. For more information on our products and vision, visit www.SunOphthalmics.com
Contamac
For over 30 years, Contamac has manufactured contact and intraocular lens materials, and has been a leading innovator of specialist polymers and biocompatible materials for medical applications. Our flagship line of Optimum® GP materials feature a wide range of oxygen permeabilities and excellent wettability to suit a variety of indications and contact lens modalities. Additionally, we offer products that are complimentary to contact lens wear and eyecare, including HyClear™, a .01% hypochlorous acid solution for daily eyelid hygiene, and Nutrifill®, a saline solution for rinsing and filling scleral and other specialty contact lenses. Visit contamac.com/products for more information.
SILVER
Tarsus
Tarsus is a biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent diseases with limited treatment options. Serving patient needs is our passion; delivering revolutionary treatments is our mission.